Metabolic Mechanisms and Potential Therapies of Diabetic Cardiac Complications.
作者信息
Qi Dake, Xia Zhengyuan, Zhuang Zhenwu
机构信息
Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, Canada A1B 3V6; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Anesthesiology, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong; Department of Anesthesiology, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
出版信息
J Diabetes Res. 2017;2017:5130496. doi: 10.1155/2017/5130496. Epub 2017 Jan 15.
Abstract
摘要
相似文献
1
Metabolic Mechanisms and Potential Therapies of Diabetic Cardiac Complications.
J Diabetes Res. 2017;2017:5130496. doi: 10.1155/2017/5130496. Epub 2017 Jan 15.
2
Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Circulation. 2015 Mar 3;131(9):795-804. doi: 10.1161/CIRCULATIONAHA.114.012285. Epub 2015 Jan 30.
3
Galanin participates in the functional regulation of the diabetic heart.
Life Sci. 2013 Mar 28;92(11):628-32. doi: 10.1016/j.lfs.2013.01.024. Epub 2013 Feb 1.
4
Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors.
J Cardiovasc Pharmacol. 2017 Aug;70(2):74-86. doi: 10.1097/FJC.0000000000000481.
5
Cardiac adaptations to obesity, diabetes and insulin resistance.
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1905-1907. doi: 10.1016/j.bbadis.2018.01.024. Epub 2018 Jan 31.
6
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Diabetologia. 2018 Jan;61(1):21-28. doi: 10.1007/s00125-017-4390-4. Epub 2017 Aug 3.
7
Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.
Biochim Biophys Acta. 2015 May;1853(5):1113-8. doi: 10.1016/j.bbamcr.2015.02.005. Epub 2015 Feb 14.
8
Novel approaches in the treatment of diabetic cardiomyopathy.
Biomed Pharmacother. 2018 Oct;106:1039-1045. doi: 10.1016/j.biopha.2018.07.051. Epub 2018 Jul 17.
9
MG53 and disordered metabolism in striated muscle.
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1984-1990. doi: 10.1016/j.bbadis.2017.10.013. Epub 2017 Oct 7.
10
MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review.
Eur J Endocrinol. 2018 Apr;178(4):R127-R139. doi: 10.1530/EJE-17-0724. Epub 2018 Feb 12.
引用本文的文献
1
Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.
Lipids. 2022 Jul;57(4-5):241-255. doi: 10.1002/lipd.12351. Epub 2022 Jul 1.
2
2'-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway.
J Diabetes Res. 2022 Apr 23;2022:2042273. doi: 10.1155/2022/2042273. eCollection 2022.
3
Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice p53/PPARα signaling.
Theranostics. 2021 Mar 4;11(10):4710-4727. doi: 10.7150/thno.51739. eCollection 2021.
本文引用的文献
1
Predictors of Atrial Fibrillation After Coronary Artery Bypass Grafting: A Bayesian Analysis.
Ann Thorac Surg. 2017 Jan;103(1):92-97. doi: 10.1016/j.athoracsur.2016.05.115. Epub 2016 Aug 28.
2
Hyperglycemia Abrogates Ischemic Postconditioning Cardioprotection by Impairing AdipoR1/Caveolin-3/STAT3 Signaling in Diabetic Rats.
Diabetes. 2016 Apr;65(4):942-55. doi: 10.2337/db15-0782. Epub 2015 Dec 30.
3
Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.
J Diabetes Res. 2015;2015:396414. doi: 10.1155/2015/396414. Epub 2015 Jul 1.
Zotero 插件